Executive record

Ann Lee, Ph.D.

Chief Technical Officer at Prime Medicine, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:ann-lee-ph-dVersion: public-0As of: 2026-09-28

Not yet claimed7 published Claims2 sources
  • Executive

Key Claims

Biography

Dr. Lee has served as Chief Technical Officer since October 2021, bringing extensive biopharmaceutical technical operations experience from senior roles at Bristol-Myers Squibb, Celgene Corporation, Juno, and Genentech. She holds a Ph.D. in biochemical engineering from Yale University and a B.S. in chemical engineering from Cornell University.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedChief Technical Officer · Prime Medicine, Inc.
  2. 2026 to end not publishedExecutive title: Chief Technical Officer · Organization not publishedPRME DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. PRME DEF 14A executive officers

    sec filing · Source published: Apr 23, 2026 · Retrieved: May 5, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at Prime Medicine, Inc. · Claim reviewed: May 5, 2026
    • Executive title: Executive title: Chief Technical Officer · Claim reviewed: May 5, 2026
    • Other Company Role: Ann Lee, Ph.D. is also linked to Coya Therapeutics, Inc. as Board Member (Audit and Compensation Committees). · Claim reviewed: May 5, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 5, 2026

  2. Open source

    sec def 14a · Source published: Apr 23, 2026 · Retrieved: Sep 12, 2026

    Supports 1 claim
    • Professional Role: Chief Technical Officer at Prime Medicine, Inc. · Claim reviewed: Sep 12, 2026